Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v1-EN
Language French English
Date Updated 2023-02-10 2023-01-10
Drug Identification Number 02392836 02392836
Brand name TARO-PREGABALIN TARO-PREGABALIN
Common or Proper name PREGABALIN PREGABALIN
Company Name SUN PHARMA CANADA INC SUN PHARMA CANADA INC
Ingredients PREGABALIN PREGABALIN
Strength(s) 75MG 75MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code N03AX N03AX
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-01-06 2023-01-06
Estimated end date 2023-02-03 2023-02-03
Actual end date 2023-02-04
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments